[Edaily Reporter KYUNG GYEYOUNG ] AMOREPACIFIC CORPORATION(090430)’s powerful mixology brand, Primera, launched the “3C-Hyaluronic Acid Hydration Surge Serum” and the “3C-Hyaluronic Acid Serum Mega Shot Gel Mask” on the 23rd.
The 3C-Hyaluronic Acid line combines hyaluronic acid with caffeine, ceramides, and cica (Caffeine·Ceramide·Cica), delivering 25% higher moisturizing efficacy compared to standard hyaluronic acid.
The 3C-Hyaluronic Acid Serum delivers moisture deep into the skin through the synergistic effect of Primera’s triple-action hyaluronic acid and caffeine, improving deep-seated dryness and providing a cooling sensation through hydration alone. With the launch of these new products, Primera has expanded its lineup to include three high-performance serums: the “Vitatinol Serum,” the “PDRN-Niacin 10 Serum,” and the “3C-Hyaluronic Acid Serum.”
Along with this, Primera also unveiled the 3C-Hyaluronic Acid Gel Mask, created by solidifying an entire bottle of the serum. The gel mask provides intensive hydration to the skin while reducing puffiness and delivering a cooling sensation. In particular, it has been shown to significantly enhance moisture retention when used in combination with the serum.
Primera first unveiled the new products the previous day on Naver’s “New Product Week” and plans to launch them sequentially through major online and offline channels, including Amore Mall and Olive Young.
The “3C Hyaluronic Acid Serum” (left) and gel mask introduced by Primera. (Photo: AMOREPACIFIC CORPORATION)
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…